Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Nov;85(10):1499–1503. doi: 10.1054/bjoc.2001.2066

A common p73 polymorphism is associated with a reduced incidence of oesophageal carcinoma

B M Ryan 1, R McManus 1, J S Daly 1, E Carton 2, P W N Keeling 1, J V Reynolds 2, D Kelleher 1
PMCID: PMC2363958  PMID: 11720435

Abstract

The incidence of oesophageal adenocarcinoma is rising; to date, no susceptibility genes have been identified. p73, a novel p53 homologue, maps to chromosome 1p36, a region commonly deleted in oesophageal cancers. p73 shares some p53-like activity, but in addition, may also play a role in gastrointestinal epithelial inflammatory responses. A non-coding p73 polymorphism (denoted AT or GC) may be functionally significant. We investigated whether this polymorphism might play a role in the aetiopathogenesis of oesophageal cancer. This was a case–control, retrospective study. 84 cases of oesophageal cancer (25 squamous and 59 adenocarcinoma) and 152 normal population controls were genotyped for this polymorphism. Informative cases were examined for p73 LOH within the tumour. AT/AT homozygotes were significantly less prevalent in the oesophageal cancer population (1/84 = 1.2%) compared to controls (15/152 = 9.9%) (P < 0.02), corresponding to an odds ratio of 0.11 (95% C.I. 0.02–0.6, P < 0.02), or 9-fold reduced risk. Moreover, AT/AT homozygotes were significantly less frequent in the cancer population than would be expected under the Hardy–Weinberg hypothesis (P = 0.0099). LOH at the p73 locus was observed in 37.8% (14/37) of the AT/GC heterozygotes studied; in all cases there was loss of the AT allele. Our findings indicate that p73 AT/AT homozygotes appear to be protected against the development of oesophageal cancer. Clinically, this observation could have implications in aiding identification of high-risk Barrett's oesophagus patients.© 2001 Cancer Research Campaign  http://www.bjcancer.com

Keywords: oesophageal cancer, p53, p73, polymorphism, genetics, risk

Full Text

The Full Text of this article is available as a PDF (65.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Altshuler D., Kruglyak L., Lander E. Genetic polymorphisms and disease. N Engl J Med. 1998 May 28;338(22):1626–1626. doi: 10.1056/NEJM199805283382214. [DOI] [PubMed] [Google Scholar]
  2. Barrett M. T., Galipeau P. C., Sanchez C. A., Emond M. J., Reid B. J. Determination of the frequency of loss of heterozygosity in esophageal adenocarcinoma by cell sorting, whole genome amplification and microsatellite polymorphisms. Oncogene. 1996 May 2;12(9):1873–1878. [PubMed] [Google Scholar]
  3. Barrett M. T., Sanchez C. A., Prevo L. J., Wong D. J., Galipeau P. C., Paulson T. G., Rabinovitch P. S., Reid B. J. Evolution of neoplastic cell lineages in Barrett oesophagus. Nat Genet. 1999 May;22(1):106–109. doi: 10.1038/8816. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bosset J. F., Gignoux M., Triboulet J. P., Tiret E., Mantion G., Elias D., Lozach P., Ollier J. C., Pavy J. J., Mercier M. Chemoradiotherapy followed by surgery compared with surgery alone in squamous-cell cancer of the esophagus. N Engl J Med. 1997 Jul 17;337(3):161–167. doi: 10.1056/NEJM199707173370304. [DOI] [PubMed] [Google Scholar]
  5. Cai Y. C., Yang G. Y., Nie Y., Wang L. D., Zhao X., Song Y. L., Seril D. N., Liao J., Xing E. P., Yang C. S. Molecular alterations of p73 in human esophageal squamous cell carcinomas: loss of heterozygosity occurs frequently; loss of imprinting and elevation of p73 expression may be related to defective p53. Carcinogenesis. 2000 Apr;21(4):683–689. doi: 10.1093/carcin/21.4.683. [DOI] [PubMed] [Google Scholar]
  6. Cohen S., Parkman H. P. Heartburn--a serious symptom. N Engl J Med. 1999 Mar 18;340(11):878–879. doi: 10.1056/NEJM199903183401109. [DOI] [PubMed] [Google Scholar]
  7. De Laurenzi V., Costanzo A., Barcaroli D., Terrinoni A., Falco M., Annicchiarico-Petruzzelli M., Levrero M., Melino G. Two new p73 splice variants, gamma and delta, with different transcriptional activity. J Exp Med. 1998 Nov 2;188(9):1763–1768. doi: 10.1084/jem.188.9.1763. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Gong J. G., Costanzo A., Yang H. Q., Melino G., Kaelin W. G., Jr, Levrero M., Wang J. Y. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage. Nature. 1999 Jun 24;399(6738):806–809. doi: 10.1038/21690. [DOI] [PubMed] [Google Scholar]
  9. Ichimiya S., Nimura Y., Kageyama H., Takada N., Sunahara M., Shishikura T., Nakamura Y., Sakiyama S., Seki N., Ohira M. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent. Oncogene. 1999 Jan 28;18(4):1061–1066. doi: 10.1038/sj.onc.1202390. [DOI] [PubMed] [Google Scholar]
  10. Jost C. A., Marin M. C., Kaelin W. G., Jr p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature. 1997 Sep 11;389(6647):191–194. doi: 10.1038/38298. [DOI] [PubMed] [Google Scholar]
  11. Kaghad M., Bonnet H., Yang A., Creancier L., Biscan J. C., Valent A., Minty A., Chalon P., Lelias J. M., Dumont X. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and other human cancers. Cell. 1997 Aug 22;90(4):809–819. doi: 10.1016/s0092-8674(00)80540-1. [DOI] [PubMed] [Google Scholar]
  12. Lagergren J., Bergström R., Lindgren A., Nyrén O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med. 1999 Mar 18;340(11):825–831. doi: 10.1056/NEJM199903183401101. [DOI] [PubMed] [Google Scholar]
  13. Levine A. J. p53, the cellular gatekeeper for growth and division. Cell. 1997 Feb 7;88(3):323–331. doi: 10.1016/s0092-8674(00)81871-1. [DOI] [PubMed] [Google Scholar]
  14. Mai M., Qian C., Yokomizo A., Tindall D. J., Bostwick D., Polychronakos C., Smith D. I., Liu W. Loss of imprinting and allele switching of p73 in renal cell carcinoma. Oncogene. 1998 Oct 1;17(13):1739–1741. doi: 10.1038/sj.onc.1202099. [DOI] [PubMed] [Google Scholar]
  15. Mai M., Yokomizo A., Qian C., Yang P., Tindall D. J., Smith D. I., Liu W. Activation of p73 silent allele in lung cancer. Cancer Res. 1998 Jun 1;58(11):2347–2349. [PubMed] [Google Scholar]
  16. Montesano R., Hollstein M., Hainaut P. Genetic alterations in esophageal cancer and their relevance to etiology and pathogenesis: a review. Int J Cancer. 1996 Jun 21;69(3):225–235. doi: 10.1002/(SICI)1097-0215(19960621)69:3<225::AID-IJC13>3.0.CO;2-6. [DOI] [PubMed] [Google Scholar]
  17. Nimura Y., Mihara M., Ichimiya S., Sakiyama S., Seki N., Ohira M., Nomura N., Fujimori M., Adachi W., Amano J. p73, a gene related to p53, is not mutated in esophageal carcinomas. Int J Cancer. 1998 Nov 9;78(4):437–440. doi: 10.1002/(sici)1097-0215(19981109)78:4<437::aid-ijc8>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  18. Nomoto S., Haruki N., Kondo M., Konishi H., Takahashi T., Takahashi T., Takahashi T. Search for mutations and examination of allelic expression imbalance of the p73 gene at 1p36.33 in human lung cancers. Cancer Res. 1998 Apr 1;58(7):1380–1383. [PubMed] [Google Scholar]
  19. Takahashi H., Ichimiya S., Nimura Y., Watanabe M., Furusato M., Wakui S., Yatani R., Aizawa S., Nakagawara A. Mutation, allelotyping, and transcription analyses of the p73 gene in prostatic carcinoma. Cancer Res. 1998 May 15;58(10):2076–2077. [PubMed] [Google Scholar]
  20. Walsh T. N., Noonan N., Hollywood D., Kelly A., Keeling N., Hennessy T. P. A comparison of multimodal therapy and surgery for esophageal adenocarcinoma. N Engl J Med. 1996 Aug 15;335(7):462–467. doi: 10.1056/NEJM199608153350702. [DOI] [PubMed] [Google Scholar]
  21. Yokomizo A., Mai M., Tindall D. J., Cheng L., Bostwick D. G., Naito S., Smith D. I., Liu W. Overexpression of the wild type p73 gene in human bladder cancer. Oncogene. 1999 Feb 25;18(8):1629–1633. doi: 10.1038/sj.onc.1202474. [DOI] [PubMed] [Google Scholar]
  22. Zhu J., Jiang J., Zhou W., Chen X. The potential tumor suppressor p73 differentially regulates cellular p53 target genes. Cancer Res. 1998 Nov 15;58(22):5061–5065. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES